Return to search

Robocath lands $43m Series C

France and UK-based Robocath, a provider of cardiovascular robotic systems for the treatment of vascular diseases, has secured $43 million in Series C financing.

France and UK-based Robocath, a provider of cardiovascular robotic systems for the treatment of vascular diseases, has secured $43 million in Series C financing. MicroPort Scientific Corporation led the round.

Source: Press Release